Article
Assessing the predictability of IDH mutation and MGMT methylation status in glioma patients using relaxation-compensated multipool CEST MRI at 7.0 T.
Neuro-oncology - 12 Nov 2018
Paech Daniel, Windschuh Johannes, Oberhollenzer Johanna, Dreher Constantin, Sahm Felix, Meissner Jan-Eric, Goerke Steffen, Schuenke Patrick, Zaiss Moritz, Regnery Sebastian, Bickelhaupt Sebastian, Bäumer Philipp, Bendszus Martin, Wick Wolfgang, Unterberg Andreas, Bachert Peter, Ladd Mark Edward, Schlemmer Heinz-Peter, Radbruch Alexander
Abstract excerpt
Background: Early identification of prognostic superior characteristics in glioma patients such as isocitrate dehydrogenase (IDH) mutation and O6-methylguanine-DNA-methyltransferase (MGMT) promoter methylation status is of great clinical importance. The study purpose was to investigate the non-invasive predictability of IDH mutation status, MGMT promoter methylation, and differentiation of low-grade versus...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
